Direct-Acting Antivirals Improve HCC-Free Survival, Liver Function in Patients with HCV Decompensated Cirrhosis
Results from the systematic review and meta-analysis demonstrated the positive effect of DAA therapy on overall survival, HCC-free survival, and liver function among patients with HCV decompensated cirrhosis compared to a non-DAA control group.